Effects of Xuezhikang, an extract of cholestin, on lipid profile and C-reactive protein: a short-term time course study in patients with stable angina
- 1 February 2005
- journal article
- clinical trial
- Published by Elsevier in Clinica Chimica Acta; International Journal of Clinical Chemistry
- Vol. 352 (1-2) , 217-224
- https://doi.org/10.1016/j.cccn.2004.09.026
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- C-reactive protein is not only an inflammatory marker but also a direct cause of cardiovascular diseasesMedical Hypotheses, 2004
- Simvastatin inhibits interleukin-6 release in human monocytes stimulated by C-reactive protein and lipopolysaccharideCoronary Artery Disease, 2003
- Simvastatin Lowers C-Reactive Protein Within 14 DaysCirculation, 2002
- Circadian Variation in Ischemic Threshold in Patients with Stable Angina: Relation to Plasma Endothelin-1Angiology, 2002
- Elevated Level of Plasma C-reactive Protein in Patients with Unstable Angina: Its Relations with Coronary Stenosis and Lipid ProfileAngiology, 2002
- Atherosclerosis — An Inflammatory DiseaseNew England Journal of Medicine, 1999
- C-Reactive Protein Is a Potent Predictor of Mortality Independently of and in Combination With Troponin T in Acute Coronary Syndromes: A TIMI 11A SubstudyJournal of the American College of Cardiology, 1998
- Cholesterol reduction rapidly improves endothelial function after acute coronary syndromesJournal of the American College of Cardiology, 1998
- Adherence to National Cholesterol Education Program Treatment goals in postmenopausal women with heart disease. The Heart and Estrogen/Progestin Replacement Study (HERS). The HERS Research GroupPublished by American Medical Association (AMA) ,1997
- A more meaningful scoring system for determining the severity of coronary heart diseaseThe American Journal of Cardiology, 1983